Amanote Research
Register
Sign In
P2.01-017 Study on the Effect of Apatinib Salvage Treatment of Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2017.09.1119
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
November 1, 2017
Authors
Z. Xu
C. Xu
W. Wang
Q. Xu
W. Zhuang
Z. Song
Y. Zhu
M. Shi
G. Chen
M. Fang
T. Lv
Y. Song
Publisher
Elsevier BV
Related search
P2.01-131 Apatinib as an Alternative for Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
CPC-017 Analysis of Survival in Patients With Advanced Non-Small Cell Lung Cancer
European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
P2.01-49 Comparision of Radiotheraphy Concurrent Weekly Treatment in Locally Advanced Unresectable Non Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.01-117 Concurrent Gene Alterations in Treatment-Naïve EGFR-Mutant Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Afatinib Treatment in Advanced Non-Small Cell Lung Cancer
Lung Cancer: Targets and Therapy
Oncology
Targeted Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
On the Pharmacogenetics of Non-Small Cell Lung Cancer Treatment
Expert Opinion on Drug Metabolism and Toxicology
Medicine
Toxicology
Pharmacology
Single‐Agent Paclitaxel in the Treatment of Advanced Non‐Small Cell Lung Cancer
Oncologist
Cancer Research
Medicine
Oncology
Individualized Treatment of Advanced Non-Small Cell Lung Cancer Based on Analytic Hierarchy Process
World Journal of Cancer Research